Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 162

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity

Open access
Niessl, Julia, Baxter, Amy E., Mendoza, Pilar, Jankovic, Mila, Cohen, Yehuda Z., Butler, Allison L., Lu, Ching-Lan, Dubé, Mathieu, Shimeliovich, Irina, Gruell, Henning, Klein, Florian, Caskey, Marina, Nussenzweig, Michel C., Kaufmann, Daniel E. · 2020 · Nature Medicine

Abstract

Combination antiretroviral therapy (ART) is highly effective in controlling human immunodeficiency virus (HIV)-1 but requires lifelong medication due to the existence of a latent viral reservoir1,2. Potent broadly neutralizing antibodies (bNAbs) represent a potential alternative or adjuvant to ART. In addition to suppressing viremia, bNAbs may have T cell immunomodulatory effects as seen for other forms of immunotherapy3. However, this has not been established in individuals who are infected with HIV-1. Here, we document increased HIV-1 Gag-specific CD8+ T cell responses in the peripheral blood of all nine study participants who were infected with HIV-1 with suppressed blood viremia, while receiving bNAb therapy during ART interruption4. Increased CD4+ T cell responses were detected in eight individuals. The increased T cell responses were due both to newly detectable reactivity to HIV-1 Gag epitopes and the expansion of pre-existing measurable responses. These data demonstrate that bNAb therapy during ART interruption is associated with enhanced HIV-1-specific T cell responses. Whether these augmented T cell responses can contribute to bNAb-mediated viral control remains to be determined. T cell responses specific for HIV-1 Gag peptides increased in HIV-positive recipients of two broadly neutralizing antibodies with prolonged suppression of blood viremia during antiretroviral treatment interruption.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-019-0747-1

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 162

Metadata

Authors
Niessl, J., Baxter, A. E., Mendoza, P., Jankovic, M., Cohen, Y. Z., Butler, A. L., Lu, C.-L., Dubé, M., Shimeliovich, I., Gruell, H., Klein, F., Caskey, M., Nussenzweig, M. C., & Kaufmann, D. E.
Venue
Nature Medicine
Published
2020-02
Volume
26
Issue
2
Pages
222-227
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3003228485
Cited by
162
References
2
FWCI
11.48
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity. https://app.cochat.ai/papers/10.1038/s41591-019-0747-1
The paper
Niessl, J., Baxter, A. E., Mendoza, P., Jankovic, M., Cohen, Y. Z., Butler, A. L., Lu, C.-L., Dubé, M., Shimeliovich, I., Gruell, H., Klein, F., Caskey, M., Nussenzweig, M. C., & Kaufmann, D. E. (2020). Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity. Nature Medicine. https://doi.org/10.1038/s41591-019-0747-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.